Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, targets a different hormone called amylin, lost as much as 20% weight.
By Vijay Kumar Malesu A new synthesis of randomized trials reveals that a carefully supervised very low-carbohydrate ...
Scientists are uncovering how GLP-1 drugs like Ozempic and Wegovy act on brain regions that control hunger, nausea, pleasure-based eating, and thirst. These discoveries may help create treatments that ...
K-pop star HyunA collapsed during her performance at the Waterbomb Macau festival after losing over 10kg in a month. Fans expressed concern for her health, emphasizing the dangers of rapid weight loss ...
Throughout her twenties, Michaela tried to slim down. The rate of loss was always maddeningly slow and all it took was a ...
Oct 23 (Reuters) - London-based telehealth startup SheMed said on Thursday it raised $50 million in a Series A round, valuing the company at $1 billion, as demand for weight-loss drugs Wegovy and ...
The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...
Amber Carter had battled with her weight for as long as she could remember. For decades, the 39-year-old from Clarkston, Michigan, had been caught in a frustrating cycle: eating a balanced diet, ...
GLP-1 medications have been a life-changing tool to help people manage their blood sugar and lose weight. But the most popular forms of these medications have a big drawback: you have to inject ...
Serena Williams showcased her dramatically transformed physique in a recent Instagram post, wearing baby blue lace-trimmed lingerie that highlighted her slender frame. The tennis champion appeared ...
Semaglutide delivers major weight-loss results, but a new study shows that most users quit within a year. Credit: Shutterstock A sweeping Danish study reveals a harsh truth about today’s most popular ...